Breast Cancer Vaccine Shows Promise
"The immune response against HER2-positive receptors we saw in this study is powerful, and works even in tumors that are resistant to current therapies."
Wayne State University research has shown that a breast cancer vaccine tested on mice totally eliminated HER2-positive tumors without toxicity.
According to a Newsmax report, it is believed the vaccine may be effective against tumors in humans, and also may prevent development of such tumors in the first place.
"The immune response against HER2-positive receptors we saw in this study is powerful, and works even in tumors that are resistant to current therapies," said study leader Wei-Zen Wei, Ph.D. "The vaccine could potentially eliminate the need to even use these therapies."
The report adds that "an earlier vaccine is being used as the basis for a vaccine currently undergoing early phase human trials in the U.S. and Europe with women stricken with HER2-positive breast cancer."
